Patent Assignment
Reel/Frame 058026/0021
Assignment of Assignor's Interest
Recorded: 2021-11-04
Pages: 5
Assignor
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Executed: 2020-05-19
Assignee
NAVIRE PHARMA, INC.
421 KIPLING STREET, PALO ALTO, CALIFORNIA, 94301
Covered Property
(1)
Substituted Heterocyclic Inhibitors of PTPN11
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 4, 2021
From: JONES, PHILIP; CROSS, JASON; BURKE, JASON; MCAFOOS, TIMOTHY
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 058026/0001 →
Security Interest
Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest
Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest in Patent Collateral
Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →